{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T02:58:43Z","timestamp":1740106723758,"version":"3.37.3"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T00:00:00Z","timestamp":1729123200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004330","name":"GSK plc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pulmonary Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.pupt.2024.102331","type":"journal-article","created":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T06:30:23Z","timestamp":1728541823000},"page":"102331","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Interaction between fluticasone furoate and umeclidinium in passively sensitized isolated human airways"],"prefix":"10.1016","volume":"87","author":[{"given":"Maria Gabriella","family":"Matera","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luigino","family":"Calzetta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Rinaldi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmela","family":"Belardo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Facciolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Filippo Tommaso","family":"Gallina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clive P.","family":"Page","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Cazzola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Rogliani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.pupt.2024.102331_bib1","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00700-2023","article-title":"Revisiting asthma pharmacotherapy: where do we stand and where do we want to go?","volume":"62","author":"Cazzola","year":"2023","journal-title":"Eur. Respir. J."},{"issue":"3","key":"10.1016\/j.pupt.2024.102331_bib2","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.04233-2020","article-title":"Triple therapy in uncontrolled asthma: a network meta-analysis of phase III studies","volume":"58","author":"Rogliani","year":"2021","journal-title":"Eur. Respir. J."},{"issue":"24","key":"10.1016\/j.pupt.2024.102331_bib3","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1001\/jama.2021.7872","article-title":"Triple vs dual inhaler therapy and asthma outcomes in moderate to severe asthma: a systematic review and meta-analysis","volume":"325","author":"Kim","year":"2021","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.pupt.2024.102331_bib4","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.jaci.2022.06.015","article-title":"Optimizing asthma management: role of long-acting muscarinic antagonists","volume":"150","author":"Casale","year":"2022","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.pupt.2024.102331_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pupt.2015.11.004","article-title":"Interaction between corticosteroids and muscarinic antagonists in human airways","volume":"36","author":"Cazzola","year":"2016","journal-title":"Pulm. Pharmacol. Ther."},{"key":"10.1016\/j.pupt.2024.102331_bib6","unstructured":"Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention (2023 update). https:\/\/ginasthma.org\/wp-content\/uploads\/2023\/07\/GINA-2023-Full-report-23_07_06-WMS.pdf."},{"key":"10.1016\/j.pupt.2024.102331_bib7","unstructured":"Expert Panel Working Group of the National Heart, Lung and Blood Institute. 2020 focused updates to the asthma management guidelines: a report from the National Asthma Education and Prevention Program Coordinating Committee Expert Panel Working Group. https:\/\/www.nhlbi.nih.gov\/resources\/2020-focused-updates-asthma-management-guidelines."},{"issue":"1","key":"10.1016\/j.pupt.2024.102331_bib8","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.rmed.2014.10.009","article-title":"A randomized, three-period crossover study of umeclidinium as monotherapy in adult patients with asthma","volume":"109","author":"Lee","year":"2015","journal-title":"Respir. Med."},{"issue":"1","key":"10.1016\/j.pupt.2024.102331_bib9","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.rmed.2014.09.012","article-title":"The effect of fluticasone furoate\/umeclidinium in adult patients with asthma: a randomized, dose-ranging study","volume":"109","author":"Lee","year":"2015","journal-title":"Respir. Med."},{"issue":"1","key":"10.1016\/j.pupt.2024.102331_bib10","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/s12931-020-01400-5","article-title":"A phase IIb, randomised, parallel-group study: the efficacy, safety and tolerability of once-daily umeclidinium in patients with asthma receiving inhaled corticosteroids","volume":"21","author":"Kerwin","year":"2020","journal-title":"Respir. Res."},{"issue":"9","key":"10.1016\/j.pupt.2024.102331_bib11","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1007\/s00228-015-1894-z","article-title":"Dose-response modelling of umeclidinium and fluticasone furoate\/umeclidinium in asthma","volume":"71","author":"Yang","year":"2015","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"5","key":"10.1016\/j.pupt.2024.102331_bib12","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1111\/bph.16272","article-title":"Use of human airway smooth muscle in vitro and ex vivo to investigate drugs for the treatment of chronic obstructive respiratory disorders","volume":"181","author":"Calzetta","year":"2024","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.pupt.2024.102331_bib13","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s12931-018-0770-7","article-title":"Beclomethasone dipropionate and formoterol fumarate synergistically interact in hyperresponsive medium bronchi and small airways","volume":"19","author":"Calzetta","year":"2018","journal-title":"Respir. Res."},{"issue":"2","key":"10.1016\/j.pupt.2024.102331_bib14","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1034\/j.1399-3003.1999.14b13.x","article-title":"Passive sensitization of human airways increases responsiveness to leukotriene C4","volume":"14","author":"Schmidt","year":"1999","journal-title":"Eur. Respir. J."},{"issue":"1\u20133","key":"10.1016\/j.pupt.2024.102331_bib15","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.ejphar.2005.12.043","article-title":"Inhibition of Rho-kinase normalizes nonspecific hyperresponsiveness in passively sensitized airway smooth muscle preparations","volume":"531","author":"Schaafsma","year":"2006","journal-title":"Eur. J. Pharmacol."},{"issue":"5","key":"10.1016\/j.pupt.2024.102331_bib16","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1111\/bph.14909","article-title":"Beclomethasone dipropionate, formoterol fumarate and glycopyrronium bromide: synergy of triple combination therapy on human airway smooth muscle ex vivo","volume":"177","author":"Rogliani","year":"2020","journal-title":"Br. J. Pharmacol."},{"issue":"20","key":"10.1016\/j.pupt.2024.102331_bib17","doi-asserted-by":"crossref","first-page":"4750","DOI":"10.1111\/bph.15240","article-title":"Targeting IL-5 pathway against airway hyperresponsiveness: a comparison between benralizumab and mepolizumab","volume":"177","author":"Calzetta","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.pupt.2024.102331_bib18","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1111\/bph.16272","article-title":"Use of human airway smooth muscle in vitro and ex vivo to investigate drugs for the treatment of chronic obstructive respiratory disorders","volume":"181","author":"Calzetta","year":"2023","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.pupt.2024.102331_bib19","doi-asserted-by":"crossref","DOI":"10.1124\/pharmrev.124.000951","article-title":"Drug-drug interactions and synergy: from pharmacological models to clinical application","author":"Calzetta","year":"2024","journal-title":"Pharmacol. Rev."},{"issue":"7","key":"10.1016\/j.pupt.2024.102331_bib20","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1111\/bph.14153","article-title":"Experimental design and analysis and their reporting II: updated and simplified guidance for authors and peer reviewers","volume":"175","author":"Curtis","year":"2018","journal-title":"Br. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.pupt.2024.102331_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1002106","article-title":"The extent and consequences of p-hacking in science","volume":"13","author":"Head","year":"2015","journal-title":"PLoS Biol."},{"issue":"5 Pt 3","key":"10.1016\/j.pupt.2024.102331_bib22","doi-asserted-by":"crossref","first-page":"S201","DOI":"10.1164\/ajrccm.158.supplement_2.13tac190","article-title":"Airway smooth muscle as a target of glucocorticoid action in the treatment of asthma","volume":"158","author":"Hirst","year":"1998","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"1","key":"10.1016\/j.pupt.2024.102331_bib23","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1073\/pnas.95.1.346","article-title":"Gsalpha-selective G protein antagonists","volume":"95","author":"Hohenegger","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.pupt.2024.102331_bib24","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1111\/j.1476-5381.1996.tb15509.x","article-title":"Regulation of histamine H1 receptor coupling by dexamethasone in human cultured airway smooth muscle","volume":"118","author":"Hardy","year":"1996","journal-title":"Br. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.pupt.2024.102331_bib25","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1165\/ajrcmb\/7.6.582","article-title":"Identification of adenylate cyclase-coupled histamine H2 receptors in Guinea pig tracheal smooth muscle cells in culture and the effect of dexamethasone","volume":"7","author":"Florio","year":"1992","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"6","key":"10.1016\/j.pupt.2024.102331_bib26","doi-asserted-by":"crossref","first-page":"L1279","DOI":"10.1152\/ajplung.00279.2001","article-title":"Eosinophil adhesion to cholinergic nerves via ICAM-1 and VCAM-1 and associated eosinophil degranulation","volume":"282","author":"Sawatzky","year":"2002","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"issue":"4","key":"10.1016\/j.pupt.2024.102331_bib27","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1172\/JCI116331","article-title":"Human eosinophil major basic protein is an endogenous allosteric antagonist at the inhibitory muscarinic M2 receptor","volume":"91","author":"Jacoby","year":"1993","journal-title":"J. Clin. Invest."},{"issue":"3 Pt 1","key":"10.1016\/j.pupt.2024.102331_bib28","first-page":"L263","article-title":"Increased acetylcholine release in tracheas from allergen-exposed IgE-immune mice","volume":"266","author":"Larsen","year":"1994","journal-title":"Am. J. Physiol."},{"issue":"5","key":"10.1016\/j.pupt.2024.102331_bib29","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1164\/ajrccm.154.5.8912735","article-title":"Incubation with IgE increases cholinergic neurotransmission in human airways in vitro","volume":"154","author":"Ichinose","year":"1996","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"3","key":"10.1016\/j.pupt.2024.102331_bib30","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1124\/pr.111.004580","article-title":"Pharmacology and therapeutics of bronchodilators","volume":"64","author":"Cazzola","year":"2012","journal-title":"Pharmacol. Rev."},{"issue":"2","key":"10.1016\/j.pupt.2024.102331_bib31","doi-asserted-by":"crossref","first-page":"L209","DOI":"10.1152\/ajplung.2000.279.2.L209","article-title":"Gs protein dysfunction in allergen-challenged human isolated passively sensitized bronchi","volume":"279","author":"Song","year":"2000","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"issue":"6","key":"10.1016\/j.pupt.2024.102331_bib32","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1111\/j.1476-5381.2012.01881.x","article-title":"Regional quantification of muscarinic acetylcholine receptors and \u03b2-adrenoceptors in human airways","volume":"166","author":"Ikeda","year":"2012","journal-title":"Br. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.pupt.2024.102331_bib33","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1513\/pats.200409-045MS","article-title":"Distribution of receptor targets in the lung","volume":"1","author":"Barnes","year":"2004","journal-title":"Proc. Am. Thorac. Soc."},{"issue":"4","key":"10.1016\/j.pupt.2024.102331_bib34","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.alit.2018.02.008","article-title":"Possible involvement of acetylcholine-mediated inflammation in airway diseases","volume":"67","author":"Koarai","year":"2018","journal-title":"Allergol. Int."},{"issue":"7","key":"10.1016\/j.pupt.2024.102331_bib35","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1111\/all.14766","article-title":"Long-acting muscarinic antagonists and small airways in asthma: which link?","volume":"76","author":"Cazzola","year":"2021","journal-title":"Allergy"},{"issue":"1","key":"10.1016\/j.pupt.2024.102331_bib36","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1164\/rccm.201412-2293OC","article-title":"Morphologic characterization of nerves in whole-mount airway biopsies","volume":"192","author":"West","year":"2015","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"2","key":"10.1016\/j.pupt.2024.102331_bib37","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1124\/jpet.112.202051","article-title":"Pharmacological characterization of GSK573719 (umeclidinium): a novel, long-acting, inhaled antagonist of the muscarinic cholinergic receptors for treatment of pulmonary diseases","volume":"345","author":"Salmon","year":"2013","journal-title":"J. Pharmacol. Exp. Therapeut."},{"issue":"11","key":"10.1016\/j.pupt.2024.102331_bib38","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1007\/s40265-023-01897-2","article-title":"Might it Be appropriate to anticipate the use of long-acting muscarinic antagonists in asthma?","volume":"83","author":"Cazzola","year":"2023","journal-title":"Drugs"},{"key":"10.1016\/j.pupt.2024.102331_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2020.106066","article-title":"The influence of smoking on asthma in the real-life","volume":"170","author":"Sprio","year":"2020","journal-title":"Respir. Med."},{"issue":"3","key":"10.1016\/j.pupt.2024.102331_bib40","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s002100100463","article-title":"NF449: a subnanomolar potency antagonist at recombinant rat P2X1 receptors","volume":"364","author":"Braun","year":"2001","journal-title":"Naunyn-Schmiedeberg\u2019s Arch. Pharmacol."}],"container-title":["Pulmonary Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094553924000476?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094553924000476?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,10]],"date-time":"2024-12-10T21:33:44Z","timestamp":1733866424000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1094553924000476"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":40,"alternative-id":["S1094553924000476"],"URL":"https:\/\/doi.org\/10.1016\/j.pupt.2024.102331","relation":{},"ISSN":["1094-5539"],"issn-type":[{"type":"print","value":"1094-5539"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interaction between fluticasone furoate and umeclidinium in passively sensitized isolated human airways","name":"articletitle","label":"Article Title"},{"value":"Pulmonary Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pupt.2024.102331","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102331"}}